In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering the integration of artificial intelligence and molecular science to transform drug discovery. Sa... Read more
Second-Quarter 2023 Revenues of $12.7 Billion Expected Decline in Paxlovid and Comirnaty(1) Revenues Drove 53% Operational Decrease in Second- Quarter 2023 Revenues Second-Quarter 2023 Revenues from Comirnaty(1... Read more
"While market trends during the quarter, especially in biopharma, were more challenging than anticipated, we leveraged the Avantor Business System to drive productivity and control costs, enabling us to deliver adjusted EBITDA margin, earning... Read more
One in Four American Adults Would Rather Not Know They Have Cancer A new study from The Harris Poll, commissioned by Bayer, suggests fear factors have an impact on diagnoses and preventative care – one in four American adults would rat... Read more
Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced the successful completion of a pre-Ser... Read more
-Brain diagnostics innovator BrainScope announced a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B equity financing round. This investment supports the ongoing development of a ... Read more
New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company’s Millipore® CTDMO Services now encompass all key stages of mRNA technologies, lipids... Read more
Charles River Laboratories International, Inc. announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The platform has the capability to reduce LVV manufacturing timelines for gene and gene-modified cell... Read more
© 2023 Biopharma Boardroom. All Rights Reserved.
